Psychotropic deprescribing across different prescribing professions in New Mexico and Louisiana
Phillip M. Hughes, Joshua D. Niznik, Robert E. McGrath, Casey R. Tak, Robert B. Christian, Betsy L. Sleath, Kathleen C. Thomas, Karli Montague-Cardoso, Karli Montague-Cardoso

TL;DR
This study compared how often different healthcare providers in New Mexico and Louisiana reduce or stop psychotropic medications over time.
Contribution
It is the first to compare deprescribing rates across psychologists, psychiatrists, and primary care physicians using real-world data.
Findings
Psychologists deprescribed without replacement more than psychiatrists but less than primary care physicians.
Psychologists reduced medication supply less than psychiatrists but more than primary care physicians.
No differences were found in complete discontinuation of psychotropic medications across provider types.
Abstract
This study aimed to assess differences in the rates of deprescribing between prescribing psychologists, psychiatrists, and primary care physicians. MarketScan private insurance claims were used to develop a longitudinal active-comparator, prevalent-user cohort of patients who were treated with a psychotropic medication from psychologists, psychiatrists, or primary care physicians for at least 90 days in New Mexico or Louisiana (states where psychologists can prescribe) between 2005–2021. The type of provider (psychologist, psychiatrist, or primary care physicians) who prescribed the psychotropic medication was the exposure of interest. Three measures of deprescribing were used as outcomes: deprescribing without replacement, complete discontinuation of prescribing, or a sustained reduction in the prescribed days’ supply. Patient demographic and clinical characteristics during the six…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMental Health Treatment and Access · Pharmaceutical Practices and Patient Outcomes · Healthcare professionals’ stress and burnout
